Pharmacotyping of childhood leukemia provides a blueprint for 'true precision medicine'



Pharmacotyping of childhood leukemia provides a blueprint for ‘true precision medicine’

Scientists have performed the largest study yet examining drug sensitivity in childhood acute lymphoblastic leukemia across genomic subtypes and its association with treatment response.

Materials provided by St. Jude Children’s Research Hospital. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

1st June 2023

Open-analysis platform for pediatric brain tumors provides robust data resource for childhood cancer research

Read more
31st May 2023

Plants remove cancer causing toxins from air

Read more
31st May 2023

How the flu virus hacks our cells

Read more